60 Degrees Pharmaceuticals Suspends Phase IIB Study of Tafenoquine for COVID-19, Pivots to Refocus on Commercialization of Treatments for Malaria and Tick-Borne Diseases
TTCR Improvement Tafenoquine v Placebo Simulated survival curve of sustained 4-day recovery from acute COVID-19…